What We're Reading: Page 241
Industry reads hand-picked by our editors
Oct 08, 2018
Oct 05, 2018
-
Bloomberg
How a Rundown Square Near Boston Birthed a Biotech Boom and Real Estate Empire
-
MarketWatch
Bio-bonds: A new way to invest in the medical miracles of the future
-
Kaiser Health News
In The Battle To Control Drug Costs, Old Patent Laws Get New Life | Kaiser Health News
-
STAT
A GOP lobbying firm helped launch the latest pro-pharma advocacy group
Oct 04, 2018
-
The Wall Street Journal
Why biotech deal-making has dried up
-
San Francisco Chronicle
Biotech startup that sells 'made to order' DNA plans to go public
-
The Hill
Drug companies fear Democratic Congress
-
Time
How scientists are treating breast cancer using the immune system
Oct 03, 2018
Oct 02, 2018
-
Scientific American
Precision medicine moves from promise to reality
-
Crain's New York Business
A biotech hub grows in Rhode Island
-
The Wall Street Journal
Patients in Canada, Mexico could face longer wait for some generic drugs
Oct 01, 2018
Sep 28, 2018
-
The Wall Street Journal
GenScript shares drop on report alleging safety violations by unit partnered with Johnson & Johnson
-
CNBC
With food allergies on the rise, drug companies ramp up new approaches
-
Reuters
UK biotech raises bumper $2 billion, despite Brexit blues
-
Philadelphia Business Journal
Where Philadelphia ranks among the top biotech clusters
Previous
